Families across the United States are suing the makers of Similac and Enfamil over a devastating gut disease called necrotizing enterocolitis, known as NEC. The NEC formula lawsuit claims these companies sold cow’s milk-based formula to hospitals knowing premature babies faced a serious risk of developing the condition, and said nothing about it.
Thousands of families have filed claims. Some have already won at trial. The legal fight is still very much active in 2026, and new families continue to join every month.
This guide covers everything you need to know. Who qualifies. What the cases have paid out so far. How the MDL works. What the 2026 deadlines look like. And what steps to take if your premature child developed NEC after being fed formula.
One stat that puts this in perspective: premature infants fed cow’s milk-based formula are up to ten times more likely to develop NEC than babies fed breast milk or donor milk, according to research published in peer-reviewed neonatal journals.
What Is the NEC Formula Lawsuit?
The NEC formula lawsuit is a product liability case against the manufacturers of premature infant formula, specifically cow’s milk-based products sold to NICUs nationwide.
The central claim is straightforward. Abbott Laboratories (maker of Similac) and Mead Johnson Nutrition (maker of Enfamil) allegedly knew for years that their cow’s milk-based formulas carried a substantially higher risk of causing necrotizing enterocolitis in premature infants. They chose not to warn hospitals or parents.
NEC is not a minor condition. It destroys intestinal tissue. Babies need emergency surgery. Many die. The ones who survive often face lifelong digestive complications.
The lawsuits allege failure to warn, negligence, strict product liability, and in some cases, fraudulent misrepresentation. Families argue that if a proper warning had existed, their doctors would have chosen safer alternatives like donor breast milk.
| Lawsuit Element | Detail |
|---|---|
| Legal Theory | Failure to warn, strict liability, negligence |
| Defendants | Abbott Laboratories, Mead Johnson Nutrition |
| Products Involved | Similac Special Care, Enfamil Premature, Human Milk Fortifiers |
| Medical Condition | Necrotizing Enterocolitis (NEC) |
| Primary Court | U.S. District Court, Northern District of Illinois |
NEC Formula Lawsuit 2026: Where Things Stand Right Now
As of 2026, the NEC formula lawsuit is one of the most active mass tort litigations in the United States.
The Illinois state court system has already produced several major verdicts, including a $60 million jury award against Abbott Laboratories in 2023 and a $500 million verdict against Abbott in a separate Cook County trial in 2024. Those cases set a powerful tone for what juries think about this issue.
In federal court, the multidistrict litigation under MDL No. 3026 continues to move cases through the bellwether process. Bellwether trials are test cases chosen to give both sides a preview of how juries will respond.
New plaintiffs are still being accepted in 2026. The litigation shows no signs of a global settlement yet, though attorneys on both sides are reportedly in discussions about potential resolution frameworks.
| Timeline Marker | Date |
|---|---|
| First Major Jury Verdict | 2023 (Cook County, IL) |
| $500 Million Illinois Verdict | 2024 |
| MDL No. 3026 Established | 2022 |
| Active Bellwether Trials | Ongoing through 2026 |
| Global Settlement Talks | Reported, no deal confirmed as of 2026 |
Key Takeaway: The NEC formula lawsuit is producing massive verdicts at trial, and the federal MDL is actively processing thousands of claims in 2026.
What Is the NEC Baby Formula Lawsuit About?
The NEC baby formula lawsuit exists because premature infants are fundamentally different from full-term babies.
A premature baby’s gut is underdeveloped. The intestinal lining is fragile. The immune system is immature. Introducing cow’s milk protein to that environment can trigger a catastrophic inflammatory response. That response is what doctors call necrotizing enterocolitis.
The scientific foundation for these lawsuits goes back decades. Multiple peer-reviewed studies, including analyses from the Cochrane Collaboration, found significantly higher rates of NEC in preterm infants fed cow’s milk formula compared to those fed human milk.
Families argue the formula companies had access to this research. They chose aggressive marketing strategies to hospitals instead of adding warning labels.
The legal claim is not that the formula caused NEC in every baby who drank it. The claim is that for vulnerable premature babies in NICUs, the risk was known and the manufacturers stayed silent.
NEC Infant Formula Lawsuit: The Full Case History
The NEC infant formula lawsuit did not emerge overnight. Legal scholars and plaintiff attorneys trace the foundation to studies from the 1990s and early 2000s showing NEC risk differences between formula-fed and breast milk-fed preemies.
The first wave of lawsuits gained traction around 2021 and 2022. Law firms began aggregating cases. By late 2022, the federal MDL was established in the Northern District of Illinois, consolidating hundreds of cases before one judge.
Illinois state courts handled cases separately under their own procedures. Those state cases moved faster and produced the first major verdicts.
The case history matters because it shows a pattern of knowledge. Internal documents obtained through discovery reportedly showed that both Abbott and Mead Johnson had access to NEC-related research years before these lawsuits were filed.
- First peer-reviewed NEC-formula studies: early 1990s
- First plaintiff law firms filing cases: 2021
- MDL established: 2022
- First major Cook County verdict: 2023
- Illinois appellate and continued trial activity: 2024 to 2026
Cow’s Milk Formula and NEC: The Science Behind the Lawsuit
The cow milk formula NEC connection is the scientific backbone of every single case in this litigation.
Breast milk contains specific proteins, antibodies, and bioactive compounds that help protect a premature baby’s gut. Cow’s milk formula lacks those protections. Worse, the proteins and fats in cow’s milk formula may actually irritate the fragile intestinal lining of a preterm infant.
Research published in medical journals over a span of 30 years has consistently found that premature babies fed cow’s milk-based formula face a materially higher risk of developing NEC compared to babies given breast milk or pasteurized donor milk.
The American Academy of Pediatrics updated its guidance in 2012 to specifically recommend breast milk for premature infants in part due to NEC risk. That guidance was available to every hospital NICU in the country.
| Feeding Type | Relative NEC Risk |
|---|---|
| Human breast milk only | Baseline (lowest risk) |
| Donor pasteurized milk | Low risk |
| Cow’s milk-based formula | Up to 10x higher risk |
| Cow’s milk human milk fortifier | Elevated risk |
Key Takeaway: Decades of peer-reviewed research showing elevated NEC risk in cow’s milk formula-fed preemies forms the scientific core of every lawsuit in this litigation.
Similac NEC Lawsuit: Abbott’s Role in the Litigation
The Similac NEC lawsuit targets Abbott Laboratories, one of the largest pharmaceutical and nutrition companies in the world.
Abbott’s Similac product line for premature infants includes Similac Special Care and Similac Human Milk Fortifier. Both are cow’s milk-based products marketed specifically for use in NICUs with premature and low-birth-weight infants.
Abbott has faced the biggest verdicts in this litigation so far. In 2023, a Cook County jury returned a $60 million verdict against Abbott in a case involving a baby who survived NEC but suffered severe long-term complications. In 2024, a separate jury awarded $500 million in a wrongful death case.
Abbott has appealed multiple verdicts. The company maintains that its products are safe when used as directed and that it has always met FDA regulatory standards.
Plaintiffs counter that FDA compliance does not shield a manufacturer from failing to warn about known risks not captured by the FDA’s existing framework.
Enfamil NEC Lawsuit: Mead Johnson’s Involvement
The Enfamil NEC lawsuit targets Mead Johnson Nutrition, now a subsidiary of Reckitt Benckiser, a British consumer goods company.
Mead Johnson’s Enfamil Premature is one of the most widely used cow’s milk formulas in American NICUs. Like Similac, it was marketed directly to hospitals as a complete nutrition solution for preterm infants.
Mead Johnson faces similar legal theories to Abbott. Families allege the company failed to warn that its formula posed a substantially elevated NEC risk for premature babies compared to human milk alternatives.
Verdicts against Mead Johnson have also reached into the tens of millions of dollars in Illinois state court proceedings.
| Defendant | Parent Company | Key Product | Court Activity |
|---|---|---|---|
| Abbott Laboratories | Abbott Laboratories | Similac Special Care | Multiple major verdicts |
| Mead Johnson Nutrition | Reckitt Benckiser | Enfamil Premature | Multiple verdicts, ongoing |
Abbott Laboratories NEC Lawsuit: Key Legal Developments
The Abbott Laboratories NEC lawsuit has become a defining chapter in modern product liability law.
Abbott is not a small company unfamiliar with litigation. It is a Fortune 500 company with a substantial legal department and deep resources. And yet, plaintiff attorneys have won repeatedly against Abbott in front of Cook County juries.
A critical development in the Abbott litigation came through discovery documents that reportedly showed internal communications about NEC risk and formula marketing decisions. Those documents became central to the punitive damages arguments in the largest verdicts.
Abbott’s legal strategy has focused on several defenses. The company argues that preterm birth itself causes NEC regardless of feeding method, that its products met all FDA standards, and that correlation in studies does not prove causation. Juries, at least in Illinois state court, have not found those arguments persuasive.
Key Takeaway: Abbott Laboratories has lost multiple multi-million-dollar verdicts in Illinois courts, and internal documents about NEC risk have played a significant role in those outcomes.
Mead Johnson NEC Lawsuit: What Families Are Alleging
The Mead Johnson NEC lawsuit mirrors the Abbott litigation in many respects but has its own procedural history.
Mead Johnson was acquired by Reckitt Benckiser in 2017 for approximately $17 billion. That acquisition means a deep-pocketed parent company stands behind any potential global settlement or continued verdict exposure.
Families filing against Mead Johnson allege that the company marketed Enfamil Premature aggressively to hospital NICUs without adequately warning medical staff about NEC risk. They argue that neonatologists and NICU nurses, if properly warned, would have sought human milk alternatives for the most vulnerable patients.
Some cases against Mead Johnson have included claims that the company’s marketing materials specifically downplayed the NEC connection in literature distributed to hospitals.
NEC MDL Lawsuit: How the Federal Case Works
The NEC MDL lawsuit refers to MDL No. 3026, formally titled “In re: Preterm Infant Formula Products Liability Litigation,” consolidated in the U.S. District Court for the Northern District of Illinois.
An MDL (multidistrict litigation) is not a class action. That distinction matters. Each case in an MDL remains an individual lawsuit with individual facts, individual injuries, and individual damages. The MDL process consolidates pre-trial proceedings, including discovery, to avoid duplicating the same work across thousands of separate federal courts.
Think of it like a school bus bringing students from across a district to one building for standardized testing. The bus is the MDL. Each student still takes their own test.
The MDL judge selects bellwether cases representing the range of claims. Those cases go to trial first. Their outcomes signal how the rest of the litigation might resolve, which often pressures defendants toward a global settlement.
| MDL Feature | Detail |
|---|---|
| Case Name | In re: Preterm Infant Formula Products Liability Litigation |
| MDL Number | 3026 |
| Court | U.S. District Court, Northern District of Illinois |
| Case Type | Individual tort claims, not class action |
| Purpose | Consolidated pre-trial proceedings |
NEC Formula Lawsuit: Who Qualifies to File a Claim?
Families generally qualify to file an NEC formula lawsuit if they meet a specific set of criteria tied to the infant’s birth status, feeding history, and medical outcome.
The core eligibility factors are:
- The child was born premature (typically before 37 weeks gestation)
- The child was fed a cow’s milk-based formula in the NICU (Similac, Enfamil, or similar)
- The child was diagnosed with NEC by a physician
- The diagnosis was documented in hospital medical records
- The NEC caused verifiable harm (surgery, hospitalization, long-term complications, or death)
Families of full-term infants who developed NEC are generally not included in these lawsuits. The scientific and legal theory centers specifically on premature infant vulnerability.
| Eligibility Factor | Required |
|---|---|
| Premature birth (before 37 weeks) | Yes |
| Cow’s milk formula fed in NICU | Yes |
| Documented NEC diagnosis | Yes |
| Medical records available | Strongly recommended |
| Harm from NEC (injury, surgery, death) | Yes |
Premature Baby Formula Lawsuit: Special Considerations for Families
The premature baby formula lawsuit carries emotional weight that most product liability cases simply do not have.
These are parents who watched their newborn fight for life in a NICU. Many made feeding decisions based entirely on what doctors and nurses recommended. They had no idea the formula carried a risk the manufacturer never disclosed.
For families still dealing with a child’s ongoing health complications from NEC, the lawsuit is not just about money. It’s about accountability.
From a legal standpoint, premature babies who survived NEC can pursue damages for medical expenses, ongoing treatment costs, pain and suffering, developmental delays, and reduced quality of life. The more severe the NEC, the higher the potential damages.
Families with strong medical records showing NEC diagnosis, surgical intervention, and documented complications tend to have the strongest cases.
Key Takeaway: Premature infants who were fed cow’s milk formula in NICUs and diagnosed with NEC are the core plaintiffs in this litigation, and medical records are the foundation of every strong claim.
NEC Wrongful Death Lawsuit Formula Cases: When a Baby Died From NEC
The NEC wrongful death lawsuit applies when a premature infant died as a result of necrotizing enterocolitis after being fed cow’s milk-based formula in a NICU.
Wrongful death cases in this litigation often carry the highest potential damage amounts. The Cook County $500 million verdict from 2024 was a wrongful death case.
Wrongful death claims in NEC cases can include:
- Medical expenses incurred before death
- Funeral and burial expenses
- Loss of companionship and parental grief (varies by state)
- Punitive damages against the formula manufacturer
State law governs who can bring a wrongful death claim. In most states, the parents are the primary claimants. Some states allow siblings or other dependents to be named as well.
The statute of limitations for wrongful death claims varies by state. Most fall between two and four years from the date of death. Some states have discovery rules that extend the clock to when the family reasonably discovered the cause.
| Damage Type | Wrongful Death NEC Case |
|---|---|
| Medical bills before death | Yes |
| Funeral costs | Yes |
| Parental grief/loss of companionship | State-dependent |
| Punitive damages | Possible, case-dependent |
| Estimated range (serious cases) | Varies widely |
NEC Formula Lawsuit Settlement Amount: What Families Can Expect
The NEC formula lawsuit settlement amount is not fixed. There is no announced global settlement as of 2026.
What exists are individual case verdicts and confidential out-of-court settlements. Based on publicly available verdict information:
- The 2023 Cook County verdict against Abbott: $60 million
- The 2024 Cook County verdict against Abbott: $500 million
- Individual confidential settlements: Estimated in the $1 million to $10 million range for serious NEC cases
These numbers reflect cases with very strong facts, documented severe injury or death, and trial-ready evidence. Not every case will produce eight-figure results.
The factors that affect settlement value most are:
- Severity of the NEC (stages 1, 2, or 3; whether surgery was needed)
- Whether the infant survived or died
- Quality of medical records and documentation
- Age of the child at time of injury
- Long-term complications and ongoing care costs
| NEC Severity | Likely Damages Range (Estimated) |
|---|---|
| Mild NEC, full recovery | Lower range, $250K to $1M |
| Moderate NEC, surgery, survival | Mid range, $1M to $5M |
| Severe NEC, permanent disability | Higher range, $5M+ |
| NEC-related wrongful death | Highest range, $5M to $500M+ at trial |
Note: These are estimates based on publicly reported verdicts. Individual outcomes vary significantly.
NEC Formula Lawsuit Verdicts: The Trial Record So Far
The NEC formula lawsuit verdict history has been strongly favorable for plaintiffs in Illinois state court.
Three notable verdicts illustrate the trend:
2023 Cook County Verdict: A jury found Abbott Laboratories liable and awarded $60 million to the family of a premature infant who survived NEC but suffered severe complications, including short bowel syndrome requiring ongoing medical management.
2024 Cook County Verdict: A second jury found Abbott Laboratories liable and awarded $500 million in a case involving a premature infant who died from NEC. This is among the largest product liability verdicts in Illinois history.
Federal MDL: Bellwether trials in the federal MDL have not yet produced final verdicts as of early 2026, but they are expected to move forward during 2026. The outcomes will significantly influence whether Abbott and Mead Johnson pursue a global settlement.
Abbott has appealed the state court verdicts. Appeals in Illinois can take one to three years to resolve through the appellate courts.
Key Takeaway: Illinois juries have returned verdicts ranging from $60 million to $500 million against Abbott Laboratories, establishing serious financial exposure for formula defendants.
NEC Formula Lawsuit Filing Deadline: Know Your Statute of Limitations
The NEC formula lawsuit filing deadline is one of the most time-sensitive aspects of this entire litigation.
Statutes of limitations vary by state. For product liability and personal injury claims in NEC cases, the window generally runs two to four years from the date of the NEC diagnosis or injury.
For wrongful death claims, the clock typically starts on the date of death. Again, this is state-specific.
Some states have a discovery rule. Under the discovery rule, the statute of limitations begins when the family knew or reasonably should have known that the formula caused the NEC. For families who only recently learned about this litigation, the discovery rule may extend their filing window.
| State Example | Standard Deadline | Wrongful Death Deadline |
|---|---|---|
| Illinois | 2 years | 2 years from date of death |
| Texas | 2 years | 2 years |
| California | 2 years | 2 years |
| New York | 3 years | 2 years |
| Florida | 2 years | 2 years |
The safest approach in 2026 is to have an attorney review your specific situation immediately. Waiting risks missing a deadline that cannot be undone.
How to File an NEC Formula Lawsuit: The Step-by-Step Process
Filing an NEC formula lawsuit begins with gathering your child’s medical records.
The process is not complicated, but it requires moving deliberately. Here are the key steps:
Step 1: Gather Medical Records
Request records from the hospital NICU where your child was treated. You need admission records, feeding logs, NEC diagnosis documents, surgical records if applicable, and discharge summaries.
Step 2: Contact a Mass Tort Attorney
Look for law firms with active experience in the NEC formula litigation. These attorneys work on contingency, meaning they charge no upfront fees. They only collect if they win.
Step 3: Case Evaluation
The attorney or their intake team reviews your records. They assess eligibility, strength of the claim, and the appropriate venue (state court vs. federal MDL).
Step 4: File the Complaint
If accepted, the attorney files a complaint naming Abbott, Mead Johnson, or both as defendants. The case is then either filed directly in state court or added to the federal MDL.
Step 5: Discovery and Case Development
Medical experts review records. Depositions happen. Evidence is exchanged. This phase can take one to three years depending on the court and case complexity.
| Filing Step | What Happens |
|---|---|
| Step 1 | Gather NICU medical records |
| Step 2 | Consult a mass tort attorney (free) |
| Step 3 | Case evaluation and review |
| Step 4 | Complaint filed in court |
| Step 5 | Discovery, expert review, litigation |
NEC Formula Lawsuit Update: The Latest in 2026
The most important NEC formula lawsuit update for 2026 is that the litigation is accelerating, not slowing down.
New plaintiffs are still being accepted. Federal bellwether trials are progressing. Both Abbott and Mead Johnson continue to defend aggressively while facing mounting verdict pressure.
The 2024 $500 million Cook County verdict sent a clear signal. Juries in Illinois are willing to assess enormous punitive damages. That financial exposure is significant. It creates real incentive for both defendants to consider a global settlement rather than continue rolling the dice in front of hostile juries.
Legal observers tracking the MDL expect 2026 to be a pivotal year. If the federal bellwether trials produce plaintiff verdicts consistent with the state court outcomes, a large-scale settlement could follow.
For families who have not yet filed, the current moment is critical. Filing now puts you in the litigation before any global settlement is announced, which generally requires active claimants to participate in the distribution.
Key Takeaway: The NEC formula lawsuit is at a critical juncture in 2026, with federal bellwether trials expected to determine whether a global settlement becomes possible.
Frequently Asked Questions
What is the NEC formula lawsuit about?
The NEC formula lawsuit holds formula makers Abbott Laboratories and Mead Johnson Nutrition liable for selling cow’s milk-based formula to NICUs without warning about the elevated NEC risk in premature infants.
Families claim that the companies knew about the scientific link between their products and NEC for years but chose not to add warning labels.
Thousands of cases are currently pending in Illinois state courts and in the federal MDL No. 3026.
Who qualifies to file an NEC formula lawsuit?
Families generally qualify if their child was born premature, was fed cow’s milk-based formula (Similac or Enfamil) in a NICU, and was diagnosed with NEC that caused documented harm.
The child must have been premature, typically under 37 weeks gestation.
Medical records documenting the NEC diagnosis and formula feeding are necessary to support the claim.
How much money can families get from an NEC formula lawsuit settlement?
There is no fixed settlement amount, but jury verdicts have ranged from $60 million to $500 million in Illinois state court.
Individual settlements negotiated out of court are estimated in the $1 million to $10 million range for serious cases.
The exact amount depends on severity of the NEC, whether the child survived, and the quality of the medical documentation.
What is the filing deadline for the NEC formula lawsuit?
The filing deadline depends on your state’s statute of limitations, which typically runs two to four years from the NEC diagnosis or death.
Some states have discovery rules that may extend the deadline if you only recently learned the formula was the cause.
The safest step is to consult with a mass tort attorney in 2026 to confirm your specific deadline before the window closes.
Which baby formula brands are named in the NEC lawsuit?
The primary formula brands named in NEC lawsuits are Similac (made by Abbott Laboratories) and Enfamil (made by Mead Johnson Nutrition, a subsidiary of Reckitt Benckiser).
Specific products include Similac Special Care, Similac Human Milk Fortifier, and Enfamil Premature.
Both companies market these formulas specifically for use with premature and low-birth-weight infants in NICUs.
What Families Should Do Right Now
The NEC formula lawsuit is real, it is active, and families are winning significant compensation. If your premature child developed NEC after being fed formula in a NICU, 2026 is the year to act.
Start by pulling your child’s hospital records. Those records are the foundation of everything.
Then connect with a mass tort attorney who handles NEC formula cases. The consultation costs nothing. The attorney reviews your records, tells you whether your case qualifies, and explains what comes next. You pay nothing unless they recover money for you.
The clock is running. Statutes of limitations are real deadlines. Every month that passes is a month you may not get back.
